Home | About Us | News & RESOURCES | CME Opportunities | Residents & MedICAL Students | Tar Wars | Quarterly Journal
News & Resources

Save the Date - Tennessee Child Heatlh Week - October 4-10, 2010

Tennessee State Loan Repayment Program (TSLRP)

Patient Safety Quality Improvement Organization Support Center MedQIC Update

          -August 2010

U.S. Food and Drug Administration Updates for Health Professionals

-June 2010

-May 2010 (update)

          -May 2010

-April 2010

-March 2010

-February 2010

-January 2010


MedWatch - The FDA Safety Information & Adverse Event Reporting Program
           -July 2010 (update)
           -July 2010

           -June 2010

           -May 2010

           -April 2010

           -March 2010

Required Official Immunization Certificate for Schools

            -Update April 2010


Volunteer State Health Plan (VSHP) Rate Reduction


Expansion of outpatient radiology prior authorization requirements for AmeriChoice by UnitedHealthcare effective February 15, 2010


Radiology Prior Authorization Program Frequently Asked Questions (FAQ) For AmeriChoice by UnitedHealthcare, Tennessee

Message from Jim King, M.D., Chair, FamMedPAC


Interest-Free Loans Available to Help Physicians Adopt Electronic Health Records


FTC Extends Enforcement Deadine for Identity Theft Red Flags Rule


Tennessee Antiviral Distribution Network 2009 H1N1 Response


Important Information for TennCare Providers
Regarding Authorization Requirements for Tamiflu


TN AFP Partnership with (Governor's Books From Birth Foundation)


Required Official Immunization Certificate for Schools


Important New TennCare Information for Physicians


Updated information on rule change related to sports physicals

Tennessee's New Smoke-free Workplace Law

CoverTN

Useful Links

 

 

FDA MedWatch - March 2010 Safety Labeling Changes:  40 drugs with changes to Boxed Warning, Warnings, Contraindications, Precautions, Adverse Reactions

 

MedWatch logoMedWatch - The FDA Safety Information and Adverse Event Reporting Program

The MedWatch March 2010 Drug Safety Labeling Changes posting includes 40 drug products with safety labeling changes to the following sections: BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, PATIENT PACKAGE INSERT, and MEDICATION GUIDE.

The "Summary Page" provides a listing of drug names and safety labeling sections revised:

http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm207384.htm

Clicking on a drug product name in the Summary View will take you to the "detailed view" page, which identifies safety labeling sections and subsections revised, along with a brief summary of new or modified safety information to the BOXED WARNING, CONTRAINDICATIONS, and/or WARNINGS sections.

The following drugs had modifications to the BOXED WARNING, CONTRAINDICATIONS, and WARNINGS sections:


Plavix (clopidogrel bisulfate)
Caduet (amlodipine besylate/atorvastatin calcium) 
Lotrel (amlodipine besylate/benazapril hydrochloride)   
Meridia (sibutramine hydrochloride)  
Skelid (tiludronate disodium)   
Avelox (moxifloxacin)   
ChloraPrep [chlorhexidine gluconate (2% w/v) and isopropyl alcohol (70% v/v)]      
DuraPrep Surgical (iodine povacrylex (0.7% available iodine) and isopropyl alcohol (74% w/w)
Emend (fosaprepitant dimeglumine)
Femara (letrozole)  
Fosamax Plus D (alendronate sodium/cholecalciferol)
Hycamtin (topotecan hydrochloride)   
Rapaflo (silodosin)  
Sustiva (efavirenz)
Toprol XL (metoprolol succinate)
Vivitrol (naltrexone for extended-release)   
Vytorin (ezetimibe/simvastatin) 
Zocor (simvastatin)

 

You are encouraged to report all serious adverse events and product quality problems to FDA MedWatch at www.fda.gov/medwatch/report.htm

Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@govdelivery.com.

This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

FDAHHS

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420